Breast Cancer Clinical Trial
Mammography SPECT With Rotating Slant Hole Collimator
Summary
The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.
Full Description
The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The motivation is the requirement of a low cost RMSSH collimator and a conventional Large-Field-Of-View (LFOV) camera. It is believed that RMSSH SPECT is particularly suitable for applications in breast imaging.
Eligibility Criteria
Inclusion Criteria:
Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.
Exclusion Criteria:
Pregnant (or possibly pregnant)
Lactating
Unable to give consent
Weights over 300 pounds
Women who have already undergone definitive surgical treatment to their breast for breast cancer will not be eligible.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Baltimore Maryland, 21287, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.